Diabetic Macular Edema

Klinik und Therapie des diabetischen Makulaödems

(2011) G. Lang et al.   KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE

Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

(2011) Michael J. Elman et al.   OPHTHALMOLOGY

A Phase 2/3, Multicenter, Randomized, Double-Masked, 2-Year Trial of Pegaptanib Sodium for the Treatment of Diabetic Macular Edema

(2011) Marla B. Sultan et al.   OPHTHALMOLOGY

The DA VINCI Study: Phase 2 Primary Results of VEGF Trap-Eye in Patients with Diabetic Macular Edema

(2011) Diana V. Do et al.   OPHTHALMOLOGY

The RESTORE Study

(2011) Paul Mitchell et al.   OPHTHALMOLOGY

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study

(2010) P. Massin et al.   DIABETES CARE

Die Rolle der Anti-VEGF-Therapie in der Behandlung des diabetischen Makulaödems

(2010) V. Kakkassery et al.   KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE

Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

(2010) Quan Dong Nguyen et al.   OPHTHALMOLOGY

Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

(2010) Michael J. Elman et al.   OPHTHALMOLOGY

A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study)

(2010) Michel Michaelides et al.   OPHTHALMOLOGY

VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells

(2008) H Deissler et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

In-vitro-Untersuchungen zum Wirkungsmechanismus von VEGF und seinen Inhibitoren

(2008) H Deissler et al.   KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE